Skip to main content
Top
Published in: Clinical Rheumatology 8/2013

01-08-2013 | Case Based Review

Diagnosing the SAPHO syndrome: a report of three cases and review of literature

Authors: Bijit Kumar Kundu, Ananta Kumar Naik, Shrinath Bhargava, Dinesh Srivastava

Published in: Clinical Rheumatology | Issue 8/2013

Login to get access

Abstract

SAPHO, an acronym for synovitis, acne, pustulosis, hyperostosis and osteitis, is a heterogeneous entity with myriad presentations and features overlapping with other entities. It is a differential in patients presenting with skin and bone symptoms, either singly or in combination. Often misdiagnosed radiologically as a malignancy or infection, the diagnosis is seldom thought of. We present three cases referred to us for evaluation of findings unrelated to the presenting symptoms. After evaluation, a 99Tc bone scan was ordered, which showed the ‘bull’s head sign’ in all the three cases, confirming the diagnosis. We review the literature for SAPHO. It has a few features which point to its diagnosis and can help us to distinguish it from other seronegative arthritis. The clinician should be aware of this entity and should not hesitate to order a 99Tc bone scan. We conclude that SAPHO is not rare, but rather, it is underdiagnosed. High index of suspicion is necessary for diagnosis. A 99Tc bone scan is diagnostic and should be ordered in patients having any of the presenting features of the syndrome. We put forward the suggestion of using 99Tc bone scintigraphy to define a ‘pre-MRI’ stage of ankylosing spondylitis.
Literature
1.
go back to reference Kahn MF, Khan MA (1994) The SAPHO syndrome. Bailliere Clin Rheumatol 8(2):333–362CrossRef Kahn MF, Khan MA (1994) The SAPHO syndrome. Bailliere Clin Rheumatol 8(2):333–362CrossRef
2.
go back to reference Cotten Anne F-R-M, Mentre A et al (1995) SAPHO syndrome. Radiographics 15:1147–1154 Cotten Anne F-R-M, Mentre A et al (1995) SAPHO syndrome. Radiographics 15:1147–1154
3.
go back to reference Chamot AM, Benhamon CL (1987) Kahn MF et al [Acne-pustulosis-hyperostosis-osteitis syndrome: result of a national survey 85 cases]. Rev Rheum Mal Osteoartic 54:187–196 Chamot AM, Benhamon CL (1987) Kahn MF et al [Acne-pustulosis-hyperostosis-osteitis syndrome: result of a national survey 85 cases]. Rev Rheum Mal Osteoartic 54:187–196
4.
go back to reference Benhamou CL, Chamot AM, Kahn MF (1988) SAPHO—a new syndrome among spondyloarthritis. Clin Exp Rheum 6(2):109–112 Benhamou CL, Chamot AM, Kahn MF (1988) SAPHO—a new syndrome among spondyloarthritis. Clin Exp Rheum 6(2):109–112
6.
go back to reference Kahn MF, Bouvier MB, Palazzo E et al (1991) Sternoclavicular pustulotic osteitis (SAPHO): 20-year interval between skin and bone lesions. J Rheumat 18:1104–1108 Kahn MF, Bouvier MB, Palazzo E et al (1991) Sternoclavicular pustulotic osteitis (SAPHO): 20-year interval between skin and bone lesions. J Rheumat 18:1104–1108
7.
go back to reference Sallés M, Olivé A, Perez-Andres R, Holgado S, Mateo L, Riera E, Tena X (2011) The SAPHO syndrome: a clinical and imaging study. Clin Rheumatol 30(2):245–249CrossRefPubMed Sallés M, Olivé A, Perez-Andres R, Holgado S, Mateo L, Riera E, Tena X (2011) The SAPHO syndrome: a clinical and imaging study. Clin Rheumatol 30(2):245–249CrossRefPubMed
8.
go back to reference Mehmat O, Kalyoncu U (2011) SAPHO syndrome may be treated effectively with combined drug regimens—a case report. IJCRI 2(1):8–11CrossRef Mehmat O, Kalyoncu U (2011) SAPHO syndrome may be treated effectively with combined drug regimens—a case report. IJCRI 2(1):8–11CrossRef
9.
go back to reference Hayem G, Bouchad-Chabot A, Benali K et al (1999) SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 29(3):159–171 Hayem G, Bouchad-Chabot A, Benali K et al (1999) SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 29(3):159–171
10.
go back to reference Grosjean C, Hurtado-Nedelec M, Nicaise-Roland P et al (2010) Prevalence of autoantibodies in SAPHO syndrome—a single centre study of 90 patients. J Rheum 37(3):639–643CrossRefPubMed Grosjean C, Hurtado-Nedelec M, Nicaise-Roland P et al (2010) Prevalence of autoantibodies in SAPHO syndrome—a single centre study of 90 patients. J Rheum 37(3):639–643CrossRefPubMed
12.
go back to reference Colina M, Govoni M, Orzincolo C, Trotta F (2009) Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum 61(6):813–821CrossRefPubMed Colina M, Govoni M, Orzincolo C, Trotta F (2009) Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum 61(6):813–821CrossRefPubMed
13.
go back to reference Hiwatani Y, Miwa H, Kondo T (2008) Aseptic meningitis as a rare manifestation of SAPHO syndrome. Neurology 71(20):1645–1647CrossRefPubMed Hiwatani Y, Miwa H, Kondo T (2008) Aseptic meningitis as a rare manifestation of SAPHO syndrome. Neurology 71(20):1645–1647CrossRefPubMed
14.
go back to reference Smith M, Buller A, Radford R, Laitt R, Leatherbarrow B (2005) Ocular presentation of the SAPHO syndrome. Br J Ophthalmol 89(8):1069–1070CrossRefPubMed Smith M, Buller A, Radford R, Laitt R, Leatherbarrow B (2005) Ocular presentation of the SAPHO syndrome. Br J Ophthalmol 89(8):1069–1070CrossRefPubMed
15.
go back to reference Assman G, Simon P (2011) The SAPHO syndrome—are microbes involved? Best Pract Res Clin Rheum 25(3):423–434CrossRef Assman G, Simon P (2011) The SAPHO syndrome—are microbes involved? Best Pract Res Clin Rheum 25(3):423–434CrossRef
16.
go back to reference Rozin AP (2009) SAPHO syndrome: is a range of pathogen-associated rheumatic diseases extended? Arthritis Res Ther 11:131CrossRefPubMed Rozin AP (2009) SAPHO syndrome: is a range of pathogen-associated rheumatic diseases extended? Arthritis Res Ther 11:131CrossRefPubMed
17.
go back to reference Assmann G, Kueck O, Kirchhoff T et al (2009) Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Re Ther 11:R140CrossRef Assmann G, Kueck O, Kirchhoff T et al (2009) Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Re Ther 11:R140CrossRef
18.
go back to reference Hurtado-Nedelec M, Chollet-Martin S, Nicaise-Roland P et al (2008) Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatol (Oxford) 47(8):1160–1167CrossRef Hurtado-Nedelec M, Chollet-Martin S, Nicaise-Roland P et al (2008) Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatol (Oxford) 47(8):1160–1167CrossRef
19.
go back to reference Colina M, Pizzirani C, Khodeir M, Simonetta F, Marco B, Francesco T et al (2010) Dysregulation of P2X7–inflammasome axis in SAPHO syndrome: successful treatment with anakinra. Rheumatology 49:1416–1418CrossRefPubMed Colina M, Pizzirani C, Khodeir M, Simonetta F, Marco B, Francesco T et al (2010) Dysregulation of P2X7–inflammasome axis in SAPHO syndrome: successful treatment with anakinra. Rheumatology 49:1416–1418CrossRefPubMed
20.
go back to reference Wendling D, Prati C, Aubin F (2012) Anakinra treatment of SAPHO syndrome: short term results of an open study. Ann Rheum Dis 71:1098–1100CrossRefPubMed Wendling D, Prati C, Aubin F (2012) Anakinra treatment of SAPHO syndrome: short term results of an open study. Ann Rheum Dis 71:1098–1100CrossRefPubMed
21.
go back to reference Golla A, Jansson A, Ramser J et al (2002) CRMO evidence for susceptibility gene on Chr 18q21.3-18q22. Eur J Hum Gen 10:217–221CrossRef Golla A, Jansson A, Ramser J et al (2002) CRMO evidence for susceptibility gene on Chr 18q21.3-18q22. Eur J Hum Gen 10:217–221CrossRef
22.
go back to reference Rohekar G, Inman RD (2006) Conundrums in nosology: synovitis, acne, pustolosis, hyperostosis, and osteitis syndrome and spondyloarthritis. Arthritis Rheum 55(4):665–669CrossRefPubMed Rohekar G, Inman RD (2006) Conundrums in nosology: synovitis, acne, pustolosis, hyperostosis, and osteitis syndrome and spondyloarthritis. Arthritis Rheum 55(4):665–669CrossRefPubMed
23.
go back to reference Hurtado-Nedelec M, Chollet-Martin S, Chapeton D, Hugot JP, Hayem G, Gérard B (2010) Genetic susceptibility factors in a cohort of 38 patients with SAPHO syndrome: a study of PSTPIP2, NOD2, and LPIN2 genes. J Rheumatol 37(2):401–409CrossRefPubMed Hurtado-Nedelec M, Chollet-Martin S, Chapeton D, Hugot JP, Hayem G, Gérard B (2010) Genetic susceptibility factors in a cohort of 38 patients with SAPHO syndrome: a study of PSTPIP2, NOD2, and LPIN2 genes. J Rheumatol 37(2):401–409CrossRefPubMed
24.
go back to reference Vermaat M, De Schepper AM, Bloem JL (2005) Sternoclavicular hyperostosis in SAPHO syndrome. JBR-BTR 88:158–159PubMed Vermaat M, De Schepper AM, Bloem JL (2005) Sternoclavicular hyperostosis in SAPHO syndrome. JBR-BTR 88:158–159PubMed
25.
go back to reference Sugimoto H, Tamura K, Fujii T (1998) The SAPHO syndrome: defining the radiological spectrum of diseases comprising the syndrome. Eur Radiol 8:800–806CrossRefPubMed Sugimoto H, Tamura K, Fujii T (1998) The SAPHO syndrome: defining the radiological spectrum of diseases comprising the syndrome. Eur Radiol 8:800–806CrossRefPubMed
26.
go back to reference Earwalker JWS, Cotton A (2003) SAPHO: syndrome or concept? Imaging findings. Skeletal Radiol 32:311–327CrossRef Earwalker JWS, Cotton A (2003) SAPHO: syndrome or concept? Imaging findings. Skeletal Radiol 32:311–327CrossRef
27.
go back to reference Laredo JD, Vuillemin-Bodaghi V, Boutry N, Cotten A, Parlier-Cuau C (2007) SAPHO syndrome: MR appearance of vertebral involvement. Radiology 242(3):825–831CrossRefPubMed Laredo JD, Vuillemin-Bodaghi V, Boutry N, Cotten A, Parlier-Cuau C (2007) SAPHO syndrome: MR appearance of vertebral involvement. Radiology 242(3):825–831CrossRefPubMed
28.
go back to reference Rodriguez QM, Tormo IC, Redal Pena MC, Castillo VL (2010) The importance of bone scintigraphy in diagnosis of SAPHO syndrome. Rev Esp Med Nucl 29(3):127–130CrossRef Rodriguez QM, Tormo IC, Redal Pena MC, Castillo VL (2010) The importance of bone scintigraphy in diagnosis of SAPHO syndrome. Rev Esp Med Nucl 29(3):127–130CrossRef
29.
go back to reference Bhosale P, Barron B, Lamki L (2001) The “SAPHO” syndrome: a case report of a patient with unusual bone scans findings. Clin Nucl Med 26(7):619–621CrossRefPubMed Bhosale P, Barron B, Lamki L (2001) The “SAPHO” syndrome: a case report of a patient with unusual bone scans findings. Clin Nucl Med 26(7):619–621CrossRefPubMed
30.
go back to reference Depasquale R, Kumar N, Lalam RK (2012) SAPHO: what radiologists should know. Clin Radiology 67(3):195–206CrossRef Depasquale R, Kumar N, Lalam RK (2012) SAPHO: what radiologists should know. Clin Radiology 67(3):195–206CrossRef
31.
go back to reference Pichler R, Weiglein K, Schmekal B, Sfetsos K, Maschek W (2003) Bone scintigraphy using Tc-99m DPD and F18-FDG in a patient with SAPHO syndrome. Scand J Rheum 32(1):58–60CrossRefPubMed Pichler R, Weiglein K, Schmekal B, Sfetsos K, Maschek W (2003) Bone scintigraphy using Tc-99m DPD and F18-FDG in a patient with SAPHO syndrome. Scand J Rheum 32(1):58–60CrossRefPubMed
32.
go back to reference Olivieri I, Padula A, Ciancio G, Salvarani C, Niccoli L, Cantini F (2002) Successful treatment of SAPHO syndrome with infliximab: report of two cases. Ann Rheum Dis 61:375–376CrossRefPubMed Olivieri I, Padula A, Ciancio G, Salvarani C, Niccoli L, Cantini F (2002) Successful treatment of SAPHO syndrome with infliximab: report of two cases. Ann Rheum Dis 61:375–376CrossRefPubMed
33.
go back to reference Iqbal M, Koldney MS (2005) Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab. J Am Acad Derm 52(5):S118–S120, SupplementCrossRefPubMed Iqbal M, Koldney MS (2005) Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab. J Am Acad Derm 52(5):S118–S120, SupplementCrossRefPubMed
34.
go back to reference Wagner AD, Andersen J, Jendro MC, Hulsemann JL, Zeidler H (2002) Sustained response to TNF-α blocking agents in two patients with SAPHO syndrome. Arth and Rheum 46(7):1965–1968CrossRef Wagner AD, Andersen J, Jendro MC, Hulsemann JL, Zeidler H (2002) Sustained response to TNF-α blocking agents in two patients with SAPHO syndrome. Arth and Rheum 46(7):1965–1968CrossRef
35.
go back to reference Massara A, Cavazzini PL, Trotta F (2006) In SAHO syndrome anti TNF-α may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology 45(6):730–733CrossRefPubMed Massara A, Cavazzini PL, Trotta F (2006) In SAHO syndrome anti TNF-α may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology 45(6):730–733CrossRefPubMed
Metadata
Title
Diagnosing the SAPHO syndrome: a report of three cases and review of literature
Authors
Bijit Kumar Kundu
Ananta Kumar Naik
Shrinath Bhargava
Dinesh Srivastava
Publication date
01-08-2013
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 8/2013
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2251-1

Other articles of this Issue 8/2013

Clinical Rheumatology 8/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.